Pyridopyrazines and the use thereof as kinase inhibitors

US7276507B2 · kind B2 · utility

Assignee

• Aeterna Zentaris, Inc. · DE

Inventors

• Eckhard Claus · Frankfurt, DE
• Eckhard Gunther · Offenbach, DE
• Irene Seipelt · Offenbach, DE
• Ulf Rapp · Würzburg, DE
• Ludmilla Wixler · Coburg, DE

Key dates

• Filing date: May 21, 2004
• Grant date: Oct 2, 2007
• Expiry date: Jan 1, 2025

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention relates to novel pyrido[2,3-b]pyrazine derivatives of the general Formula I, their preparation and use as medicaments, in particular for the treatment of malignant and other disorders based on pathological cell proliferations